久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Latest

China approves patent to COVID-19 vaccine

By Zhang Zhihao | chinadaily.com.cn | Updated: 2020-08-16 19:15
Share
Share - WeChat
A woman holds a small bottle labeled with a "Vaccine COVID-19" sticker and a medical syringe in this illustration taken on April 10, 2020. [Photo/Agencies]

China has granted its first COVID-19 vaccine patent to the adenovirus vector vaccine developed by Chen Wei of the Academy of Military Medical Sciences and Chinese biotech company CanSino Biologics, according to the National Intellectual Property Administration.

The patent was submitted for application on March 18, and was approved on Aug 11, according to the patent document.

The vaccine, dubbed "Ad5-nCoV", uses a weakened common cold virus to introduce genetic material from the novel coronavirus into the human body. The goal is to train the body to produce antibodies that recognize the coronavirus’s spike protein and fight it off.

The phase-two clinical trial of the vaccine has found it is safe and can induce an immune response, according to research published in the journal Lancet last month. The phase-three clinical trial, which will include more participants and be conducted overseas, is currently in the pipeline.

Experts have called adenovirus vector vaccine a promising technique for its safety and potency against COVID-19 based on current evidence, as well as its potential in mass production. The United Kingdom and Russia are also working on a vaccine candidate using this kind of technology.

However, many pressing questions regarding the vaccine candidate remain, such as the longevity of the protection, the appropriate dosage to trigger a strong immune response, and whether there are host-specific differences. These questions will be probed in the larger scale phase-three trials.

Another caveat is that with the vector for the vaccine being a common cold virus, people may have preexisting immunity that kills the viral carrier before the vaccine can take effect, which could partially hamper the immune responses.

Compared with younger people, older participants generally had significantly lower immune responses, the Lancet study found. As a result, elderly people might require an additional dose to induce a stronger immune response, but further research would be needed to evaluate this approach.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 欧美一级看片免费观看视频在线 | 国产a一级毛片午夜剧院 | 国产成人综合网在线观看 | 国产精品日本一区二区不卡视频 | 色播亚洲精品网站 亚洲第一 | 激情丝袜美女视频二区 | 国产精品高清在线 | 欧美激情国内自拍偷 | 亚洲第一页在线播放 | 久久精品国产免费观看99 | 久久综合精品国产一区二区三区无 | 欧美日韩一区二区三区在线观看 | 国产日韩精品欧美一区喷 | 免费一级欧美片片线观看 | 国产在线观看高清精品 | 欧美一级在线毛片免费观看 | 最新国产三级在线观看不卡 | 免费国产高清精品一区在线 | 中日韩欧美一级毛片 | 毛片免费观看的视频在线 | www日本高清视频 | 99re热久久| 色久网| 国产精品女在线观看 | 日韩视频精品在线 | 亚洲国产第一区二区香蕉日日 | 直接看的毛片 | 老司机黄色影院 | 男女福利视频 | 欧美特级视频 | 国产精品久久久久久久久久影院 | 日韩精品免费一级视频 | 国产精品久久久久久久久免费 | 免费一级真人毛片 | 欧美一级大黄特黄毛片视频 | 最新国产成人综合在线观看 | 国产精品所毛片视频 | 波多野结衣一区二区 三区 波多野结衣一区二区三区88 | 亚洲视频在线观看地址 | 免费一级毛片在级播放 | 亚洲欧美一区二区三区在线播放 |